Steward Partners Investment Advisory’s Soleno Therapeutics SLNO Stock Holding History

Steward Partners Investment Advisory’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22	Closed	-$737	–	4845
2026 Q1	$737	Hold	22	–	–	﹤0.01%	4230
2025 Q4	$1.02K	Hold	22	–	–	﹤0.01%	4085
2025 Q3	$1.49K	Buy	+22	New	+$1.63K	﹤0.01%	3988

Steward Partners Investment Advisory's SLNO Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 22 shares — an estimated $737 sold.

Steward Partners Investment Advisory first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $1.49K in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 22 Soleno Therapeutics shares in Q2 2026, an estimated $737.
Steward Partners Investment Advisory first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
Steward Partners Investment Advisory's Soleno Therapeutics position peaked at $1.49K in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.